Elevation Point Wealth Partners LLC Takes Position in The Allstate Corporation $ALL

Posted by Brenda Bartman on Aug 23rd, 2026

Elevation Point Wealth Partners LLC purchased a new position in The Allstate Corporation (NYSE:ALL – Free Report) in the second quarter, Holdings Channel.com reports. The fund purchased 22,019 shares of the insurance provider’s stock, valued at approximately $5,259,000.

Other large investors have also added to or reduced their stakes in the company. Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in shares of Allstate by 5.1% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 552,120 shares of the insurance provider’s stock valued at $112,533,000 after purchasing an additional 26,586 shares during the period. Strategic Global Advisors LLC grew its stake in Allstate by 19.2% in the fourth quarter. Strategic Global Advisors LLC now owns 48,882 shares of the insurance provider’s stock worth $10,175,000 after purchasing an additional 7,870 shares during the period. CIBC Asset Management Inc raised its holdings in Allstate by 69.2% in the fourth quarter. CIBC Asset Management Inc now owns 63,011 shares of the insurance provider’s stock worth $13,116,000 after purchasing an additional 25,764 shares in the last quarter. Bank of America Corp DE raised its holdings in Allstate by 8.1% in the first quarter. Bank of America Corp DE now owns 7,913,320 shares of the insurance provider’s stock worth $1,640,748,000 after purchasing an additional 596,321 shares in the last quarter. Finally, International Assets Investment Management LLC purchased a new position in Allstate during the fourth quarter valued at $161,000. Institutional investors own 76.47% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently commented on ALL. Cantor Fitzgerald boosted their target price on shares of Allstate from $236.00 to $242.00 and gave the company a “neutral” rating in a report on Thursday, July 9th. JPMorgan Chase & Co. increased their price target on shares of Allstate from $282.00 to $292.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 11th. Citigroup cut shares of Allstate from a “neutral” rating to a “sell” rating and lifted their price target for the company from $226.00 to $240.00 in a research report on Tuesday, August 11th. UBS Group boosted their price objective on shares of Allstate from $261.00 to $275.00 and gave the stock a “neutral” rating in a research note on Monday, August 10th. Finally, Keefe, Bruyette & Woods restated an “underperform” rating and issued a $250.00 price objective (down from $255.00) on shares of Allstate in a report on Thursday. Four analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, eight have issued a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat, Allstate presently has a consensus rating of “Hold” and a consensus target price of $265.26.

View Our Latest Stock Analysis on Allstate

Insider Buying and Selling at Allstate

In other news, COO Mario Rizzo sold 56,225 shares of the company’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $264.48, for a total value of $14,870,388.00. Following the transaction, the chief operating officer owned 82,227 shares in the company, valued at approximately $21,747,396.96. This represents a 40.61% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider John E. Dugenske sold 32,996 shares of the stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $269.33, for a total transaction of $8,886,812.68. Following the sale, the insider owned 13,054 shares in the company, valued at approximately $3,515,833.82. The trade was a 71.65% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 91,446 shares of company stock worth $24,208,675. 1.55% of the stock is owned by corporate insiders.

Allstate Trading Down 0.3%

Allstate stock opened at $253.82 on Friday. The Allstate Corporation has a 12 month low of $188.08 and a 12 month high of $277.22. The company has a market capitalization of $64.18 billion, a price-to-earnings ratio of 5.07, a price-to-earnings-growth ratio of 0.39 and a beta of 0.16. The business’s fifty day simple moving average is $250.34 and its two-hundred day simple moving average is $224.95. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.24.

Allstate (NYSE:ALL – Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The insurance provider reported $8.99 earnings per share for the quarter, beating the consensus estimate of $6.06 by $2.93. The firm had revenue of $18.60 billion during the quarter, compared to the consensus estimate of $15.46 billion. Allstate had a return on equity of 41.64% and a net margin of 18.97%.The company’s revenue was up 11.8% on a year-over-year basis. During the same period last year, the company earned $5.94 earnings per share. As a group, equities analysts predict that The Allstate Corporation will post 34.45 earnings per share for the current fiscal year.

Allstate Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Monday, August 31st will be given a dividend of $1.08 per share. This represents a $4.32 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend is Monday, August 31st. Allstate’s dividend payout ratio is 8.63%.

Key Headlines Impacting Allstate

Here are the key news stories impacting Allstate this week:

Positive Sentiment: Zacks Research raised several Allstate EPS forecasts, including estimates for Q3 2026, FY2027, FY2028, Q1 2027, Q4 2027 and Q2 2028. Zacks maintains a “Strong-Buy” rating, supporting the view that underwriting performance and earnings power may remain resilient. Allstate earnings estimates
Positive Sentiment: A Zacks screen identified ALL as a high-return-on-equity, cash-rich stock that could appeal to investors seeking quality and financial strength during volatile markets. High-ROE stocks article
Neutral Sentiment: Allstate opened a new Dallas auto laboratory to train claims adjusters on increasingly complex vehicle technology. The initiative could improve claims accuracy and customer service over time, but it is unlikely to materially affect near-term earnings. Allstate Dallas auto lab
Negative Sentiment: Keefe, Bruyette & Woods downgraded ALL from “hold” to “moderate sell,” adding to investor caution around the stock’s valuation and outlook. Allstate analyst downgrade
Negative Sentiment: Allstate estimated July catastrophe losses of $682 million pretax, or $539 million after tax. The losses bring pretax catastrophe costs for the current aggregate year to approximately $2.402 billion, creating pressure on underwriting margins and near-term earnings. Allstate July 2026 monthly release
Negative Sentiment: Zacks Research lowered its Q2 2027 and Q4 2026 EPS estimates, indicating that analysts still see some periods of earnings pressure despite upward revisions elsewhere. Allstate earnings estimates

About Allstate

(Free Report)

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.